miscsubjectsAI governance
Evidence review

TB-500 for Postherpetic Neuralgia: Evidence Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-postherpetic`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-postherpetic

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-postherpetic/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-postherpetic/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-postherpetic/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-postherpetic/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
This is the largest single-authored interlocked logical structure published in the open that I am aware of: thousands of objects — a theory of everything, a theory of AI, and a replicated decision framework — where every piece fits every other piece, and every claim carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. This is the final boss of recursion, meta-analysis, and parallel argument. Come at a node.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.

Why TB-500 might help you

  1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • TB-500 → inflammation clearance / repair-cell migration

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 2
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 6

Quantified confidence (this ledger): 0.25 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Peptide Therapy for Pain Management and Healing (source s1)

Clinic overview of TB-500 mechanisms; no PHN-specific trials mentioned.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice (source s2)

2012 mouse study on diabetic neuropathy recovery.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

How Dr. Lundquist is Using BPC-157, TB-500 ... (source s4)

Description of TB-500 mechanisms in pain and healing context.

Evidence type: Published research.

What people say on Reddit

Had Shingles Two years ago, recent flair up 6 months ... — Reddit, r/shingles (source s5)

User anecdote on TB-500 use post-shingles.

BCP157/TB500 shingles? — Reddit, r/bpc_157 (source s6)

Additional Reddit context on peptide use with shingles.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Postherpetic neuralgia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 6 sources · swipe →chain d3cf2646ee18 · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
preclinical
Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models.
sources: s2, s3
humanlow confidence
No human clinical trials exist for TB-500 in postherpetic neuralgia.
sources: s1
mechanisticlow confidence
TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair.
sources: s4
anecdotallow confidence
Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data.
sources: s5, s6
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:33
TB-500 for Postherpetic Neuralgia: Evidence Review · 4 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Postherpetic
Slug: tb-500-postherpetic
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenera
it output
{
  "slug": "tb-500-postherpetic",
  "title": "TB-500 for Postherpetic Neuralgia: Evidence Review",
  "body": "## What's breaking down\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## How these fit together\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n\n## What the evidence actually shows\nNo human clinical trials exist for 
ea93ba94d71d55f2
Machine verification: /api/articles/tb-500-postherpetic/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models."?
ask tb-500-postherpetic claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No human clinical trials exist for TB-500 in postherpetic neuralgia."?
ask tb-500-postherpetic claim c1 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair."?
ask tb-500-postherpetic claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data."?
ask tb-500-postherpetic claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on TB-500 use post-shingles."
ask tb-500-postherpetic source s5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Additional Reddit context on peptide use with shingles."
ask tb-500-postherpetic source s6 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for Postherpetic Neuralgia: Evidence Review — and what would you need me to tell you first?
ask tb-500-postherpetic condition gaps · paste includes §SELF
What good and bad outcomes are documented for TB-500 for Postherpetic Neuralgia: Evidence Review (studies vs anecdotes)?
ask tb-500-postherpetic good bad experiences · paste includes §SELF
tb-500-postherpetic · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 15446 tokens · $0 · 2 models
chain head 81db4b8853871e12
write grok/grok-4.3 · 2026-06-29 23:33 · 15446 tok · be75cf2ee3ff
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · 81db4b885387
verify chain →
Live ledger · 4 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 10:25
JCI_CLASSIFY jci · HTTP 200 · 2026-07-19 10:25
PROTOCOL_RUN dispatch · 2026-06-29 23:33 · t_6knk2wbx
PROTOCOL_RUN dispatch · 2026-06-29 23:33 · t_6knk2wbx
view full ledger & cards →
REST + ledger
read GET /api/articles/tb-500-postherpetic · GET /api/articles/tb-500-postherpetic?format=post (the editable body)
create/replace POST /api/articles/tb-500-postherpetic · PUT /api/articles/tb-500-postherpetic (replace, keeps revision) · PATCH /api/articles/tb-500-postherpetic (merge)
delete DELETE /api/articles/tb-500-postherpetic
writes need header x-terminal-key
LLM bundle GET /api/articles/tb-500-postherpetic/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim tb-500-postherpetic|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →